LONDON (Alliance News) - A spin-off company of GlaxoSmithKline PLC is considering a possible stock-market flotation after strong results for its new painkiller, the Financial Times reported Sunday. Convergence Pharmaceuticals was spun off in 2010 when Glaxo restructured its research and dev Read More
LONDON (Alliance News) - UK residential and commercial property companies are among the biggest fallers in a declining market Friday, after Bank of England Governor Mark Carney said the interest rates in the UK could rise sooner than investors expect and Chancellor of the Exchequer George Osbo Read More
LONDON (Alliance News) - The following is a summary of top news stories Friday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>Petra Diamonds</strong> Ltd shares jumped to the top of the FTSE 250 index after saying it has recovered another exceptional 122.52 carat Read More
LONDON (Alliance News) - The deteriorating situation in Iraq has depressed shares early Friday, as the UK market also contemplates a sooner-than-expected rise in interest rates by the Bank of England.<br /><br /><strong>SSE</strong>,<strong> Tullow Oil</strong> and <strong>BG Group</strong> le Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Friday a late stage study of its drug eltrombopag for the treatment of chronic immune thrombocytopenia in paediatric patients had met its primary endpoint. Immune thrombocytopenia is a bleeding disorder where the blood does not clot properly Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning and Wednesday afternoon:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />NOMURA CUTS BG GROUP TO 'NEUTRAL' ('BUY') - PRICE TARGET 1350 PENCE<br />----------<br />TRADERS: INVE Read More
LONDON (Alliance News) - Healthcare giant GlaxoSmithKline PLC Wednesday said a group of executives, including Chief Executive Officer Andrew Witty, acquired shares under the ShareReward Plan at a price of 1598.59 pence per share Tuesday.<br /><br />Details are as follows.<br /><br /> <table Read More
LONDON (Alliance News) - <strong>J Sainsbury</strong> Wednesday reported another drop in like-for-like sales, its second consecutive quarterly decline after nine years of unbroken sales growth. <br /><br />The UK's third-largest supermarket chain by market share posted a 1.1% decline in like-f Read More
LONDON (Alliance News) - GlaxoSmithKline PLC and Theravance Inc Wednesday announced positive results for two late stage studies of Incruse Ellipta when combined with Relvar Breo Ellipta for the treatment of chronic obstructive pulmonary disease. The two phase III studies using the combined Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Monday said K Slaoui, connected person of divisional chairman Moncef Slaoui, bought 4 American Depositary Shares under the GSK 401K plan at a price of USD53.70 per ADS. Glaxo ADR shares were up 0.4% at USD53.92 Monday afternoon. By Rowena H Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Thursday that it has begun a phase III study to evaluate its Iosmapimod drug in patients with acute coronary syndrome. The study will evaluate whether the drug can reduce the risk of cardiac events such as heart attacks when administered twi Read More
LONDON (Alliance News) - The European Central Bank on Thursday cut its key interest rate to a record low and embraced a negative deposit rate, the first for a leading central bank, as it tries to fight the low inflation that is threatening to derail the euro area's fragile economic recovery.<b Read More
LONDON (Alliance News) - The following is a summary of top news stories Thursday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br />UK pharmaceutical giant<strong> GlaxoSmithKline</strong> PLC has agreed to a USD105 million settlement covering 44 US states over allegations t Read More
LONDON (Alliance News) - <strong>ASOS</strong> is dragging down the AIM All-Share Index at the open Thursday after lowering its profit guidance. The online fashion retailer, by far the biggest AIM stock by market capitalisation, dropped 40% at the open and was down 34% a half hour into trading Read More
LONDON (Alliance News) - UK pharmaceutical giant GlaxoSmithKline PLC has agreed to a USD105 million settlement covering 44 US states over allegations that it unlawfully promoted its asthma treatment Advair and antidepressants Paxil and Wellburtin. As part of the settlement, announced on Wed Read More
LONDON (Alliance News) - UK pharmaceutical giant GlaxoSmithKline PLC has agreed to a USD105 million settlement covering 44 US states over allegations that it unlawfully promoted its asthma treatment Advair and antidepressants Paxil and Wellburtin. As part of the settlement, announced on Wed Read More
LONDON (Alliance News) - The FTSE 100 started the month on the front foot Monday, closing higher, after a gauge of China's factory activity rose to a five-month high in May, suggesting the world's second-largest economy is stabilising after a subdued start to the year.<br /><br />China's offic Read More
LONDON (Alliance News) - <strong>GlaxoSmithKline</strong> has signed a collaboration and licensing agreement with UK-based biotechnology company Adaptimmune Ltd for its cancer programme, a move that comes just weeks after it agreed to sell its own cancer drug business to Novartis as part of a Read More
LONDON (Alliance News) - UK based biotechnology company Adaptimmune Ltd confirmed Monday that it had entered into a collaboration and licensing agreement with pharmaceutical giant GlaxoSmithKline PLC worth a potential USD350 million over the next seven years, for its cancer programme. Under Read More
LONDON (Alliance News) - UK based biotechnology company Adaptimmune Ltd confirmed Monday that it had entered into a collaboration and licensing agreement with pharmaceutical giant GlaxoSmithKline PLC worth a potential USD350 million over the next seven years, for its cancer programme. Under Read More